Abstract
Currently, cervical cancer is one of the widest-spread forms of malignant neoplasms. This disease occupies seventh place in incidence among all malignant neoplasms and third place in women (after mammary and colorectal cancers). Recently, a considerable increase in frequency of diagnosing different forms of cervical cancer in young women (up to 40 years old) has been observed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Belhocine T, De Barsy C, Hustinx R, Willems-Foidart J (2002) Usefulness of (18)F-FDG PET in the post-therapy surveillance of endometrial carcinoma. Eur J Nucl Med Mol Imaging 29:1132–1139
Benedet JL, Bender H, Jones H et al (2000) FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancer. Int J Gynaecol Obstet 70:209–262
Chang TC, Law KS, Hong JH et al (2004) Positron emission tomography for unexplained elevation of serum squamous cell carcinoma antigen levels during follow-up for patients with cervical malignancies: a phase II study. Cancer 101:164–171
Dehdashti F, Grigsby PW, Mintun MA, Lewis JS, Siegel BA, Welch MJ (2003) Assessing tumor hypoxia in cervical cancer by positron emission tomography with 62Cu-ATSM: relationship to therapeutic response – a preliminary report. Int J Radiat Oncol Biol Phys 55:1233–1238
Grigsby PW, Siegel BA, Dehdashti F, Rader J, Zoberi I (2004) Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome. J Clin Oncol 22:2167–2171
Grit K, Horn LC, Fisher U et al (2001) 18F-FDG positronen-Emissions-Tomographie bei Zervixkarzinom: Erste Ergebnisse. Zbl Gynacol 123(4):229–235
Havrilesky LJ, Kulasingam SL, Matchar DB, Myers ER (2005) FDG-PET for management of cervical and ovarian cancer. Gynecol Oncol 97:183–191
Jang HJ, Lee KH, Kim YH et al (2002) The role PET for predicting prognosis in squamous cell type uterine cervical carcinoma patients. J Nucl Med 43(Suppl 3):28P
Lai CH, Huang KG, See LC et al (2004) Restaging of recurrent cervical carcinoma with dual-phase [18F]fluoro-2-deoxy-D-glucose positron emission tomography. Cancer 100:544–552
Lapela M, Leskinen-Kallio S, Varpula M et al (1994) Imaging of uterine carcinoma by carbon-11-methionine and PET. J Nucl Med 35:1618–1623
Ma SY, See LC, Lai CH et al (2003) Delayed (18)F-FDG PET for detection of paraaortic lymph node metastases in cervical cancer patients. J Nucl Med 44:1775–1783
Park W, Park YJ, Huh SJ et al (2005) The usefulness of MRI and PET imaging for the detection of parametrial involvement and lymph node metastasis in patients with cervical cancer. Jpn J Clin Oncol 35:260–264
Saga T, Higashi T, Ishimori T et al (2003) Clinical value of FDG-PET in the follow up of post-operative patients with endometrial cancer. Ann Nucl Med 17:197–203
Singh AK, Grigsby PW, Dehdashti F et al (2003) FDG-PET lymph node staging and survival of patients with FIGO stage IIIb cervical carcinoma. Int J Radiat Oncol Biol Phys 56:489–493
Torizuka T, Kanno T, Futatsubashi M et al (2003) Imaging of gynecologic tumors: comparison of (11)C-choline PET with (18)F-FDG PET. J Nucl Med 44:1051–1056
Umesaki N, Tanaka T, Miyama M et al (2001a) Positron emission tomography using 2-[(18)F] fluoro-2-deoxy-D-glucose in the diagnosis of uterine leiomyosarcoma: a case report. Clin Imaging 25:203–205
Umesaki N, Tanaka T, Miyama M et al (2001b) Positron emission tomography with (18)F-fluorodeoxyglucose of uterine sarcoma: a comparison with magnetic resonance imaging and power Doppler imaging. Gynecol Oncol 80:372–377
Wong TZ, Jones EL, Coleman RE (2004) Positron emission tomography with 2-deoxy-2-[(18)F]fluoro-D-glucose for evaluating local and distant disease in patients with cervical cancer. Mol Imaging Biol 6:55–62
Yen TC, Lai CH, Wu YH et al (2002) Glut-1 expression in invasive cervical cancer. Eur J Nucl Med Mol Biol 29(Suppl):266
Yen TC, Ng KK, Ma SY et al (2003) Value of dual-phase 2-fluoro-2-deoxy-D-glucose positron emission tomography in cervical cancer. J Clin Oncol 21:3651–3658
Yen TC, See LC, Chang TC et al (2004) Defining the priority of using 18F-FDG PET for recurrent cervical cancer. J Nucl Med 45:1632–1639
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Granov, A., Tiutin, L., Schwarz, T. (2013). Cervical and Endometrial Cancers. In: Granov, A., Tiutin, L., Schwarz, T. (eds) Positron Emission Tomography. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-21120-1_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-21120-1_13
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-21119-5
Online ISBN: 978-3-642-21120-1
eBook Packages: MedicineMedicine (R0)